THS International  

SONABLATE® 500

Using leading edge technology, the Sonablate® 500 utilizes HIFU - High Intensity Focused Ultrasound - to treat prostate disease non-invasively.

 

QUALITY OF LIFE

 

We are committed to improving the quality of life for patients faced with the decision of treating cancer.  We believe that HIFU offers a patient-friendly and intelligent solution in this rapidly evolving world of medical care.

HIFU Technology
Clinical Publications
References

HIFU NEWS

FDA Approves Sonablate® 500 Phase III Clinical Study

 

Subdistributors
Contact Us